JNJ-42226314

• Description :

  JNJ-42226314 is a highly selective non-covalent monoacylglycerol lipase (MAGL) inhibitor with anti-injury effects.JNJ-42226314 shows efficacy via endogenous cannabinoid-2-acryloylglycerol (2-AG) in models of neuropathic pain and inflammatory pain.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  489.56

• Molecular Formula :

  C26H24FN5O2S

• Notes :

  Research use only, not for human use.

• Receptor :

  Lipase

• CAS Number :

  1252765-13-1